Abstract:9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one (KY‐31) displayed relatively low toxicity and retained anti‐inflammatory activity with a higher selectivity index compared to 9‐aminacrine (9‐AA). It may exert its anti‐inflammatory effects through the nuclear receptor subfamily 4 group A member 1 (NR4A1)/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway and inhibit the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). These findings support further development and exploration of 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one as a promising anti‐inflammatory compound for inflammatory conditions. 9‐aminacrine (9‐AA), an external antibacterial agent, possesses important bioactivities for the treatment of cancer, viruses, and prion diseases. Recent research has revealed that 9‐AA has anti‐inflammatory effects through the up‐regulation of nuclear receptor subfamily 4 group A member 1 (NR4A1), but it is highly cytotoxic. To mitigate its toxicity, three series of novel 9‐AA derivatives were synthesized. The toxicity of all compounds was assessed, and some of the less toxic compounds were tested for in vitro anti‐inflammatory activities, leading to the establishment of structure‐activity relationships. In particular, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one exhibited relatively low toxicity and retained anti‐inflammatory activity, with a higher selectivity index compared to 9‐AA (3.44 versus 0.68). Expression experiments of inflammatory mediators revealed that this compound not only inhibited the gene expression of pro‐inflammatory factors, but also promoted the gene expression of anti‐inflammatory factors. Preliminary mechanistic studies suggested that it exerted anti‐inflammatory effects through the NR4A1/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway. Furthermore, molecular docking studies indicating that it may exhibit anti‐inflammatory activity by inhibiting the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). Based on our data, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one with its low toxicity and anti‐inflammatory properties, holds promise for further development as an anti‐inflammatory agent.

Synthesis and Anti-inflammatory Analgesic Activities of 2-(2,6-dichlorophenylamino)-benzeneacetic Acid(3-nitroxymethyl) Phenyl Ester

Synthesis and Anti-inflammatory Activity of Nitric Oxidedonating α-Substituted p-(Methanesulfonyl)phenylpropenoic Acid Esters

Synthesis and Anti-inflammatory Activity of Resacetophenone Derivatives

Synthesis and Anti-Inflammatory Activity Evaluation of Novel 3-Alkyl-6-(4h-1,2,4-triazol-4-yl)-3,4-dihydro-2h-benzo[e][1,3]oxazine Derivatives

Synthesis and Anti-Inflammatory Activity of Α-Substituted P-(Methanesulfonyl)phenylpropenamides

Synthesis and biological evaluation of N-(benzene sulfonyl)acetamide derivatives as anti-inflammatory and analgesic agents with COX-2/5-LOX/TRPV1 multifunctional inhibitory activity

Synthesis and Biological Activity of 3-[(4-sulfamoylphenyl)hydroxy Methylene]-5-methyl-2-oxindole-1-carboxamides

[Synthesis and Anti-Inflammatory Activity of P-(Methanesulfonyl) Styrene-Linked Cyclic Ketone Derivatives].

Synthesis and anti-inflammatory activity ofhydroxamic acid and acyl urea derivatives ofp-(methanesulfonyl)phenylpropenoic acids

Design, Synthesis, Biological Evaluation and Docking Study of A New Series of 9‐aminoacridine Derivatives as Anti‐inflammatory Agents

Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

N-[2-(5,5-dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: their synthesis, anti-inflammatory evaluation and QSAR analysis.

Synthesis and Anti-inflammatory Activity of α-Substituted p-Methylsulfonylcinnamic Acids

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives As Potent Anti-Inflammatory Agents

Pharmacological Evaluation of 9,10-Dihydrochromeno[8,7- E ][1,3]Oxazin-2(8 H )-One Derivatives As Potent Anti-Inflammatory Agent

Discovery of a novel inhibitor of nitric oxide production with potential therapeutic effect on acute inflammation

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents

Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo

Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents

A Experimental Study on the Anti-inflammatory Activity and Gastrointestinal Lesions of Α-Substituted P-Methylsulfonylphenylpropenoic Acids

Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents.